A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG
Tumor Necrosis Factor
Trial Locations (1)
941102859
San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco
All Listed Sponsors
lead
University of California, San Francisco
OTHER
NCT00002262 - A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter